Sinnovial

Sinnovial, an innovative Company based in Grenoble, has identified predictive and clinical-ready biomarkers for rheumatoid diseases and implemented them into the SinnoTest®, an online precision medicine software ranking several biological Disease-Modifying Anti-Rheumatoid Drugs (bDMARDs) for each patient based on its predicted efficacy (responder or not). SinnoTest® is a unique prediction tool designed by and for rheumatologists to ensure biotherapy efficacy, improve patients’ quality of life and save huge overcosts for society.

SinnoTest® is to become the new gold standard in Chronic Inflammatory Diseases biotherapy prescription